National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
NCI Drug Dictionary

iodine I 131 monoclonal antibody BC8
A radioimmunoconjugate consisting of BC8, a murine IgG1 anti-CD45 monoclonal antibody labeled with iodine 131 (I-131), with radioimmunotherapeutic properties. Using monoclonal antibody BC8 as a carrier for I-131 results in the targeted destruction of cells expressing CD45. CD45 is tyrosine phosphatase expressed on virtually all leukocytes, including myeloid and lymphoid precursors in bone marrow and mature lymphocytes in lymph nodes; it is also expressed on most myeloid and lymphoid leukemic cells, but not on mature erythrocytes or platelets. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:I 131 Monoclonal Antibody BC8
iodine I 131 MOAB BC8
Abbreviation:I 131 MOAB BC8

Previous:iodine I 131 ethiodized oil, Iodine I 131 Lipiodol, iodine I 131 monoclonal antibody 3F8, iodine I 131 monoclonal antibody 81C6, iodine I 131 monoclonal antibody 8H9
Next:iodine I 131 monoclonal antibody CC49-deltaCH2, iodine I 131 tositumomab, iodine-123 metaiodobenzylguanidine, Iodotope, ipilimumab